Skip to content

01349.HK

Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.

HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN

HKD 2.61
+3.78%
Ask drillr
  • Aug 14, 2026, 10:32 UTC

    Fudan Zhangjiang Bio-Pharmaceutical reported interim results for the six months ended June 2026, with net profit of 36.895 million RMB, up 545% year-on-year.